A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)
NCT00457470 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-05-04
Summary
This study will evaluate the safety and efficacy of AG-014699 in diabetic patients
Conditions
Interventions
- DRUG
-
AG-014699
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
More Related Trials
-
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
NCT02914613 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Macugen for Ischaemic Diabetic Macular Oedema
NCT01175070 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients
NCT07199777 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
NCT05224102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema
NCT06422507 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Combination Steroid and Anti-VEGF for Persistent DME
NCT01945866 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
NCT05759884 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema
NCT00799227 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Ascending Dose Cohort Study of AG-73305 in DME Patients
NCT05301751 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
NCT03590444 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)
NCT03666923 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
NCT04527107 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)
NCT03511898 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
NCT02302079 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome
NCT05080803 ·Status: COMPLETED
-
Treatment of Refractory Diabetic Macular Edema With Infliximab
NCT00505947 ·Status: TERMINATED ·Phase: PHASE3
-
Describing Patient With DME, Their Patient Journey and Disease Progression
NCT05966753 ·Status: COMPLETED
-
A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients
NCT06237777 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison of Initial Treatment in With Laser Grid in Diabetic Macular Edema to Intra Vitreal Avastin Injections
NCT01769599 ·Status: UNKNOWN
-
Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema
NCT04697758 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
NCT06205979 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Laser and Medical Treatment of Diabetic Macular Edema
NCT00027287 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema
NCT05343156 ·Status: COMPLETED ·Phase: PHASE2
-
The Study to YD312 Tablet in Patients With Diabetic Macular Edema
NCT03635814 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME)
NCT01324869 ·Status: COMPLETED ·Phase: PHASE1/PHASE2